Schedule 13D ownership disclosure
Viridian Therapeutics Inc
Security class unavailable · CUSIP: 92790C104
Event date: 2023-05-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-071200
- Form type
- SC 13D
- Filer
- Atlas Venture Fund VII L P
- CIK
- CIK 1346450
- Filed
- Jun 14, 2023
- Reporting period
- May 23, 2023
- Description
- Schedule 13D beneficial ownership